Questions arise on antiulcerant effect of COX-2 inhibitor

Published: 2002-12-31 06:58:00

Updated: 2002-12-31 06:58:00

Cyclooxygenase-2 (COX-2) inhibitor, a novel nonsteroidal anti-inflammatory drug (NSAID), has been used to treat arthritis by highlighting its advantage in advertisement over other NSAIDs in that COX-2 inhibitor causes less inflammation and ulceration of the stomach and intestine.

The salient point for advertising COX-2 inhibitor is that it inhibits prostaglandins, chemicals that causes the ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.